aTENSION.life
Generated 5/11/2026
Executive Summary
aTENSION.life is an Austrian diagnostics startup redefining hypertension care through precision diagnosis and personalized treatment. Founded in 2020 and headquartered in Vienna, the company aims to address the global burden of hypertension, a leading cause of cardiovascular disease, by developing novel diagnostic tools that enable earlier detection and tailored therapy. aTENSION's approach leverages advanced biomarkers and data analytics to stratify patients beyond traditional blood pressure measurements, potentially improving outcomes and reducing healthcare costs. The company operates in the high-growth precision diagnostics market, with hypertension affecting over 1.4 billion people worldwide, presenting a significant opportunity for innovation.
Upcoming Catalysts (preview)
- Q4 2026Completion of Proof-of-Concept Study70% success
- Q2 2027CE Marking Application50% success
- Q3 2027Commercial Partnership for Distribution40% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)